New drugs for old? What is the role of B-cell receptor pathway inhibition in the front line therapy of CLL in 2017?
EHA Learning Center. Devereux S. Jun 25, 2017; 184552
Stephen Devereux
Stephen Devereux
Login now to access Regular content available to all registered users.

Access to EHA Members only content is an EHA membership benefit.
Click here to join EHA or renew your membership here.

Discussion Forum (0)
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions